• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharma Advanced Research Company Limited — Board Meeting, 10-08-2026: Outcome of Board Meeting

    10-08-2026 | 01:34 pm

    SPARC's board approved Q1 financial results, posting a consolidated loss of ₹20.78 Cr. Revenue stood at ₹39.92 Cr. The board also approved reclassification requests for some promoter group individuals to the public category, pending regulatory nods.

    No comments yet. Be the first to comment!

    All announcements from Sun Pharma Advanced Research Company Limited